SciELO - Scientific Electronic Library Online

 
vol.87 número3Valor predictivo del calculador de riesgo quirúrgico pediátrico National Surgical Quality Improvement Program - Pediatrics en pacientes de una unidad de neonatología: estudio retrospectivo correlacionalFactores asociados a la sobrevida de los pacientes receptores de trasplante hepático por carcinoma hepatocelular según los criterios de Milán índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Cirugía y cirujanos

versão On-line ISSN 2444-054Xversão impressa ISSN 0009-7411

Resumo

MANTEROLA, Carlos; GRANDE, Luis; OTZEN, Tamara  e  CONEJEROS, Roque. Extension of surgical treatment and adjuvant chemotherapy in patients with incidental gallbladder cancer. Cir. cir. [online]. 2019, vol.87, n.3, pp.313-320.  Epub 29-Nov-2021. ISSN 2444-054X.  https://doi.org/10.24875/ciru.18000596.

Objective:

To describe the results of the extension of surgical treatment and adjuvant chemotherapy (ACT) in incidental gallbladder cancer (CVB), in terms of postoperative morbidity (POM) and 5-year overall survival rate.

Method:

Case series of patients operated on for incidental GBC in Clínica Mayor, Temuco, Chile (2001-2016). All cases were treated by partial hepatectomy (segments IVb and V), and regional lymphadenectomy. The minimum follow-up time was 12 months. Outcome variables were MPO and 5-year overall survival rate. Other variables of interest were: infiltration depth in vesicular wall, lymph nodes and resected liver; surgical time, need for reoperation, hospital stay, follow-up and mortality. Descriptive statistics were applied as well as bivariate analysis applying Fisher's exact and t-test and non-parametrical tests for continuous variables and Kaplan Meier curves.

Results:

The series was composed of 50 patients, whose average age was 58.6 ± 9.6 years; 68.0% of which were women. The mean surgical time and hospital stay were 224 ± 93 min (90 to 480) and 6.9 ± 2.9 days (4 to 20), respectively. POM was 28.0%. 5-year overall survival rate was 47%. There were no reoperations or mortality.

Conclusions:

The results verified in terms of POM and 5-year overall survival rate are similar to previously reported series.

Palavras-chave : Gallbladder cancer; Hepatectomy; Lymphadenectomy; Chemotherapy Adjuvant; Laparoscopic cholecystectomy; Kaplan-Meier.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )